( May 12, 2026, 3:07 PM EDT) -- WICHITA FALLS, Texas — The U.S. Food and Drug Administration urged a Texas federal court to stay a case brought by Florida and Texas that challenges the FDA’s approval in 2000 of mifepristone, one of two drugs used to induce early termination of pregnancy, and stay the agency’s subsequent approvals while the U.S. Supreme Court considers a motion for a stay in a related case challenging the FDA’s 2023 decision that removed the in-person dispensing requirement for the drug....